Insider Stock Trading History of Wennogle Lawrence P.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Wennogle Lawrence P. since year 2005. The trader's CIK number is 1585663. At the time of this reporting, Wennogle Lawrence P. is the Vice President, Drug Discovery of Intra-cellular Therapies, Inc. . (stock ticker symbol NONE). See this page for all insider trading activities at Intra-cellular Therapies, Inc. .


Stock purchases, sales, and option exercises reported by insider Wennogle Lawrence P. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-08 ITCI Intra-cellular Therapies, Inc. Sale 25,000 26.84 671,000
2015-05-19 ITCI Intra-cellular Therapies, Inc. Option Ex 47,500 1.24 58,900
2014-10-16 ITCI Intra-cellular Therapies, Inc. Sale 5,152 15.00 77,280
2014-10-13 ITCI Intra-cellular Therapies, Inc. Sale 1,600 15.00 24,000
2014-10-15 ITCI Intra-cellular Therapies, Inc. Sale 2,004 15.00 30,060
2014-10-08 ITCI Intra-cellular Therapies, Inc. Sale 4,745 15.00 71,175
2014-10-03 ITCI Intra-cellular Therapies, Inc. Sale 15,863 15.00 237,945
2014-10-06 ITCI Intra-cellular Therapies, Inc. Sale 636 15.00 9,540
2014-09-15 ITCI Intra-cellular Therapies, Inc. Sale 5,000 15.00 75,000
2014-07-21 ITCI Intra-cellular Therapies, Inc. Option Ex 37,500 .50 18,750
2014-05-27 ITCI Intra-cellular Therapies, Inc. Sale 5,000 15.00 75,000
2014-05-22 ITCI Intra-cellular Therapies, Inc. Sale 6,000 15.00 89,970
2013-12-16 NONE Intra-cellular Therapies, Inc. Option Ex 12,500 .30 3,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wennogle Lawrence P. (Vice President, Drug Discovery of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.